Form 4 for CYTK CYTOKINETICS INC
Accepted 2021-08-02 00:00:00 ET · period of report 2021-08-02 · accession 0001061983-21-000200 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-02 | 2021-08-02 | CYTK | Cragg David | Chief HR, Admin Off | S - Sale | $29.67 | -2,616 | 152.5K | -2% | -$77.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-02 | S | D | 2,616 | $29.67 | 152,542 | D | — | — | (F2) Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan. |